Document is current
Any future updates will be listed below
-
Authors
Wu, Lawrence W.
Jang, Sung Joo
Shapiro, Cameron
Fazlollahi, Ladan
Wang, Timothy C.
Ryeom, Sandra W.
Moy, Ryan H. https://orcid.org/0000-0002-0507-8590
-
Funding
Funding for this research was provided by:
National Cancer Institute (K08CA263304, 5T32CA203703-09)
- License Information
-
More Information
Article History
Accepted: 30 August 2024
First Online: 13 September 2024
Declarations
:
: LWW is supported by the NIH/NCI Molecular Oncology Training Program (5T32CA203703-09), and RHM is supported by grants from the NIH (K08CA263304) and Gastric Cancer Foundation. This publication is supported by NIH/NCI Cancer Center Support Grant P30CA013696.
: Lawrence W. Wu, Sung Joo Jang, Cameron Shapiro, Ladan Fazlollahi, and Timothy C. Wang have no relevant conflicts of interest to declare that may be relevant to the contents of this article. Sandra W. Ryeom has undertaken consulting work for AttisLab and has received research support from ImmPACT Bio. Ryan H. Moy has undertaken consulting work for Puretech Health, served on the Advisory Board for IDEAYA Biosciences and Nimbus Therapeutics, and has received research funding, paid to the institution, from Nimbus Therapeutics and Repare Therapeutics.
: Not applicable.
: Not applicable.
: All authors consent to the publication of this article.
: No datasets were generated or analyzed during this study.
: Not applicable.
: LWW and RHM proposed the review topic. LWW wrote the original draft of this article. LF provided representative images of diffuse-type and intestinal-type gastric cancer. All authors have reviewed, revised, and provided critical feedback on the manuscript, and provided final approval of the manuscript.
